Celiac Disease: What You Should Know as a Provider

Registration


There is not a cost to view this presentation. 

You must login or create an account before enrolling in this educational activity. 

Once you're logged in, please click the "ENTER" button to your right. Your attendance will then be confirmed. 

Once you register for the course, you will have 30 days (approximately 1 month) from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
 

Target Audience

Health professionals.

Educational Need

Experts in celiac disease agree the #1 barrier to its diagnosis is providers failing to recognize its clinical picture and consider it in their differential diagnosis. According to Fasano et al (2003), this could be because they believe it is a rare disease and/or it only manifests as diarrhea in children. 

Rubio-Tapia et al (2012) demonstrated the prevalence of celiac disease in the United States is 0.71%, or 1 in 141. An earlier study by Fasano et al (2003) showed the prevalence is 0.75%, or 1 in 133 in the not-at-risk population of the United States. Therefore, it is not a rare disease. Additionally, Rubio et al (2012) concluded the vast majority of cases (83%) are not diagnosed. 

This educational activity is designed to increase provider awareness of celiac disease and to give you the tools necessary to suspect, diagnose, and possibly even manage a patient with celiac disease. My aim is to increase your scope of understanding of celiac disease.

Learning Objectives

  • Define celiac disease.
  • Identify the epidemiology of celiac disease (who, when, and where).
  • Review the pathogenesis of celiac disease.
  • Recognize the varying clinical presentations of celiac disease (classical and non-classical).
  • Recognize how to diagnose someone with celiac disease, as well as the role of screening.
  • Treat a patient who has been diagnosed with celiac disease.
  • Treat the serious complications of celiac disease.
  • List conditions that are linked to celiac disease.

Speaker

Matt Hill, PA-S
Des Moines University

Relevant to the content of this educational activity, Mr. Hill has no financial relationships with commercial interest companies to disclose. 

Terms of Use and Privacy Policy

Date of original release: April 30, 2019
Most recent review/update: April 30, 2019
Termination date: April 29, 2022

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON
Course opens: 
04/30/2019
Course expires: 
04/29/2022
Cost:
$0.00

Continuing Education Credit

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity  for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
  • Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

DISCLOSURE

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON

Price

Cost:
$0.00
Please login or Create an Account to take this course.